“…A total of 1777 participants were included in the present review; of which 1319 participants (74.2%) had bone metastases, and 1132 participants (63.7%) were allocated to an exercise intervention ( Figure 2 ). Seventeen trials (65.4%) included participants with prostate cancer [ 8 , 9 , 10 , 11 , 13 , 14 , 15 , 17 , 20 , 21 , 22 , 23 , 24 , 26 , 30 , 31 , 32 ]; 11 trials (42.3%) included participants with breast cancer [ 8 , 10 , 12 , 14 , 17 , 18 , 19 , 20 , 22 , 27 , 34 ]. Trials that recruited participants with mixed tumours (including breast and prostate) accounted for 65.4% (17 trials) [ 8 , 10 , 14 , 17 , 20 , 22 , 25 , 28 , 29 , 32 , 34 ] ( Figure 2 ).…”